secwatch.observer — SEC 8-K summary
======================================

Issuer:     Eton Pharmaceuticals, Inc. (ETON)
CIK:        0001710340
Form:       8-K
Filed at:   2025-06-20T23:59:59+00:00
Accession:  0001437749-25-020916
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Eton Pharmaceuticals dismisses auditor Crowe, appoints Grant Thornton
---------------------------------------------------------------------

- Effective June 13, 2025, Eton dismissed Crowe LLP as its independent auditor.
- No disagreements or reportable events occurred during Crowe's tenure (fiscal year 2024).
- Audit Committee appointed Grant Thornton LLP as new auditor for fiscal year 2025.
- Crowe's audit report for FY 2024 was unqualified; no adverse opinions or modifications.
- Company provided Crowe with disclosures; Crowe's letter filed as Exhibit 16.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1710340/000143774925020916/0001437749-25-020916-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1710340/000143774925020916/eton20250613_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-020916

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer